by Clinical Neuropsychologist Online | Thursday, March 14, 2024 | Dementia
Alzheimer’s &Dementia, EarlyView. If you do not see content above, kindly GO TO SOURCE. Not all publishers encode content in a way that enables republishing at Neuro.vip. This post is Copyright: | March 14, 2024 Wiley: Alzheimer’s & Dementia: Table...
by Clinical Neuropsychologist Online | Thursday, March 14, 2024 | Dementia
Abstract Prior authorization criteria for Federal Drug Administration (FDA) approved immunotherapeutics, among the class of anti-amyloid monoclonal antibodies (mAbs), established by state drug formulary committees, are tailored for adults with late-onset...
by Clinical Neuropsychologist Online | Thursday, March 14, 2024 | Neurorehabilitation
Rehabilitation Psychology, Vol 69(4), Nov 2024, 301-314; doi:10.1037/rep0000545Purpose: Parallel process modeling (PPM) can be used to analyze co-occurring relationships between health and psychological variables over time. A demonstration is provided using data...
by Clinical Neuropsychologist Online | Wednesday, March 13, 2024 | Dementia
Abstract INTRODUCTION Depressive symptoms are associated with higher risk of dementia, but how they impact cognition in diverse populations is unclear. METHODS Asian, Black, Latino, or White participants (n = 2227) in the Kaiser Healthy Aging and Diverse Life...
by Clinical Neuropsychologist Online | Wednesday, March 13, 2024 | Dementia
Abstract INTRODUCTION We aimed to investigate the effect of apolipoprotein E4 (APOE) ε4 on synaptic density in cognitively impaired (CI) participants. METHODS One hundred ten CI participants underwent amyloid positron emission tomography (PET) with 18F-florbetapir and...
